ChromoGenics AB logo

CHRO TO3 - ChromoGenics AB News Story

SEK3 -0.2  -6.3%

Last Trade - 12:05pm

Sector
Consumer Cyclicals
Size
Micro Cap
Market Cap £13.0m
Enterprise Value £9.86m
Revenue £1.25m
Position in Universe 1517th / 1831

BRIEF-Chromogenics Q3 Operating Loss Narrows To SEK 14.4 Mln

Fri 13th November, 2020 7:44am
Nov 13 (Reuters) - ChromoGenics AB  CHRO.ST :
    * Q3 NET SALES FOR PERIOD AMOUNTED TO SEK 3.5 (14.0) MILLION
    * Q3 OPERATING LOSS AMOUNTED TO SEK -14.4 (-19.4) MILLION
    * NET SALES FOR CURRENT YEAR ARE THEREFORE EXPECTED TO BE
LOWER
THAN OUTCOME IN 2019
    * COST SAVINGS HAVE HAD GREATEST IMPACT IN Q3
    * CASH AND CASH EQUIVALENTS AMOUNTED TO SEK 21.3 (48.2)
MILLION ON
SEPTEMBER 30, 2020
    * CHROMOGENICS' ORDER BACKLOG AMOUNTED TO SEK 5.4 MILLION AT
END
OF Q3

Source text for Eikon:  ID:nWkr6c3qKt 
Further company coverage:  CHRO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587785110;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.